Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Serologic Markers for the Diagnosis of Irritable Bowel SyndromePayerPolicy · BCBSNJ-PATHOLOGY-040-5A0EDF56DD | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Alpha-Fetoprotein-L3 for Detection of Hepatocellular (Liver) CancerPayerPolicy · BCBSNJ-PATHOLOGY-039-AA5831302F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Automated Point-of-Care Nerve Conduction TestsPayerPolicy · BCBSNJ-MEDICINE-044-4F912612F2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion SyndromePayerPolicy · BCBSNJ-SURGERY-094-4995CA001F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)PayerPolicy · BCBSNJ-PATHOLOGY-038-D5001CE547 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Analysis of Proteomic Patterns in Serum to Identify CancerPayerPolicy · BCBSNJ-PATHOLOGY-037-AE8641C324 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Vision Therapy or Orthoptic Therapy for the Treatment of Visual Disorders or Learning DisabilitiesPayerPolicy · BCBSNJ-TREATMENT-112-031FE5A85F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary DysmenorrheaPayerPolicy · BCBSNJ-SURGERY-090-75CED18C05 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · BCBSNJ-PATHOLOGY-030-17E0A422F8 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | ThermographyPayerPolicy · BCBSNJ-RADIOLOGY-054-9D764DBDDC | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Genetic Testing for Helicobacter Pylori TreatmentPayerPolicy · BCBSNJ-PATHOLOGY-029-C4C17D2026 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress IncontinencePayerPolicy · BCBSNJ-TREATMENT-110-203D4F7E15 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | HippotherapyPayerPolicy · BCBSNJ-TREATMENT-106-C8CBFDCE1A | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Isolated Limb Perfusion/Isolated Limb Infusion for Malignant MelanomaPayerPolicy · BCBSNJ-SURGERY-083-483B2C8B89 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Gene Expression-Based Assays for Cancers of Unknown PrimaryPayerPolicy · BCBSNJ-PATHOLOGY-024-52406D2125 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Endoscopic Radiofrequency Ablation or Cryoablation for Barrett EsophagusPayerPolicy · BCBSNJ-TREATMENT-105-8408F20ADD | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transcranial Magnetic Stimulation as a Treatment of Disorders Other Than Psychiatric/Behavioral Health-Related ConditionsPayerPolicy · BCBSNJ-TREATMENT-104-B0AC7490EA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal CancerPayerPolicy · BCBSNJ-PATHOLOGY-023-11798D4DD0 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Assisted Reproductive TechnologiesPayerPolicy · BCBSNJ-OBSTETRICS-011-647331611C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Microwave Thermotherapy for Primary Breast CancerPayerPolicy · BCBSNJ-MEDICINE-040-04819A72E0 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Therapy for Non-Small-Cell Lung CancerPayerPolicy · BCBSNJ-RADIOLOGY-040-DD7159ADD5 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Therapy for Prostate CancerPayerPolicy · BCBSNJ-RADIOLOGY-039-99975511EA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Therapy for Breast CancerPayerPolicy · BCBSNJ-RADIOLOGY-038-9B47B83C20 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Therapy for Brain MetastasesPayerPolicy · BCBSNJ-RADIOLOGY-037-106F8FB51F | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Therapy for Bone MetastasesPayerPolicy · BCBSNJ-RADIOLOGY-036-E7872B183E | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Inhaled Nitric OxidePayerPolicy · BCBSNJ-TREATMENT-101-2A45E39F84 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body CompositionPayerPolicy · BCBSNJ-RADIOLOGY-034-CDE42AB6FA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Balloon Ostial Dilation as an Alternative to Endoscopic Sinus Surgery for Treatment of Chronic RhinosinusitisPayerPolicy · BCBSNJ-SURGERY-077-032636EECB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Subtalar ArthroereisisPayerPolicy · BCBSNJ-SURGERY-076-EAC9F4013D | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Laboratory Tests for Heart and Kidney Transplant RejectionPayerPolicy · BCBSNJ-PATHOLOGY-018-C62CAE14B2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Lumbar Spinal FusionPayerPolicy · BCBSNJ-SURGERY-073-E4CC55A6FC | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · BCBSNJ-PATHOLOGY-016-7E1B72E3C2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular RiskPayerPolicy · BCBSNJ-PATHOLOGY-014-428A58D8D0 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Hematopoietic Cell Transplantation for Waldenstrom MacroglobulinemiaPayerPolicy · BCBSNJ-TREATMENT-083-B3807934DE | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Nerve Graft with Radical ProstatectomyPayerPolicy · BCBSNJ-SURGERY-070-6B311174F2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Percutaneous Tibial Nerve StimulationPayerPolicy · BCBSNJ-SURGERY-069-26865DBD5A | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Intravenous Anesthetics for the Management of Chronic Pain and DepressionPayerPolicy · BCBSNJ-DRUGS-035-405E53C085 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Immune Globulin Subcutaneous (Hizentra, Gammagard Liquid, Gamunex-C/Gammaked, HyQvia, Cuvitru, Cutaquig, and Xembify for Subcutaneous Administration)PayerPolicy · BCBSNJ-DRUGS-045-EEF5008B75 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Drug Therapy for Hereditary Angioedema [Cinryze, Berinert, Haegarda (Human C1 Inhibitor), Kalbitor (Ecallantide), Firazyr (Icatibant), Ruconest (C1 Esterase Inhibitor [Recombinant]), Takhzyro (lanadelumab-flyo)]PayerPolicy · BCBSNJ-DRUGS-063-5CE01BD5D5 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Romiplostim (Nplate)PayerPolicy · BCBSNJ-DRUGS-062-1C16239772 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Multibiomarker Disease Activity Blood Test for Rheumatoid ArthritisPayerPolicy · BCBSNJ-PATHOLOGY-107-27C65F15C0 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Cone Beam Computed TomographyPayerPolicy · BCBSNJ-RADIOLOGY-053-C39ABCCD70 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BCBSNJ-PATHOLOGY-015-896D161A95 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Emapalumab-lzsg (Gamifant)PayerPolicy · BCBSNJ-DRUGS-187-D20745B7A0 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Moxetumomab Pasudotox-tdfk (Lumoxiti)PayerPolicy · BCBSNJ-DRUGS-186-DBB7BD3893 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Cemiplimab-rwlc (Libtayo)PayerPolicy · BCBSNJ-DRUGS-185-0D79CE48DB | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Mogamulizumab-kpkc (Poteligeo)PayerPolicy · BCBSNJ-DRUGS-184-9A116BE663 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Radiation Treatment with Azedra (Iobenguane I-131)PayerPolicy · BCBSNJ-DRUGS-183-A7F5055E19 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Patisiran (Onpattro)PayerPolicy · BCBSNJ-DRUGS-182-8171B432A4 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Burosumab-twza (Crysvita)PayerPolicy · BCBSNJ-DRUGS-180-61BD1379FC | New policy |
|---|